DexCom, Inc.
DE ˙ DB ˙ US2521311074
62,20 € ↓ -0,20 (-0,32%)
2026-06-04
DEL PRIS
SecurityDE:DC4 / DexCom, Inc.
InstitutionQube Research & Technologies Ltd
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Qube Research & Technologies Ltd ownership in DC4 / DexCom, Inc.

On May 15, 2026 - Qube Research & Technologies Ltd filed a 13F-HR form disclosing ownership of 0 shares of DexCom, Inc. (DE:DC4) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 151,947 shares of DexCom, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Qube Research & Technologies Ltd has a history of taking positions in derivatives of the underlying security (DC4) in the form of stock options. The firm currently holds call options representing 34,300 of underlying shares valued at $2,154,040 USD and put options representing 50,100 of underlying shares valued at $3,146,280 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:DC4 / DexCom, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F DEXCOM COM 252131107 0 -151,947 -100.00 0 -100.00
2026-02-17 2025-12-31 13F DEXCOM COM 252131107 151,947 -145,938 -48.99 10,085 -49.69 0.0102
2025-11-14 2025-09-30 13F DEXCOM COM 252131107 297,885 -1,333,458 -81.74 20,045 -85.92 0.0207
2025-08-14 2025-06-30 13F DEXCOM COM 252131107 1,631,343 931,998 133.27 142,400 198.17 0.1447
2025-05-15 2025-03-31 13F DEXCOM COM 252131107 699,345 -382,590 -35.36 47,758 -43.24 0.0554
2025-02-14 2024-12-31 13F DEXCOM COM 252131107 1,081,935 -638,178 -37.10 84,142 -27.03 0.1103
2024-11-14 2024-09-30 13F DEXCOM COM 252131107 1,720,113 1,484,112 628.86 115,316 330.98 0.1700
2024-08-14 2024-06-30 13F DEXCOM COM 252131107 236,001 226,395 2,356.81 26,758 1,908.78 0.0423
2024-05-14 2024-03-31 13F DEXCOM COM 252131107 9,606 1,247 14.92 1,332 28.45 0.0021
2024-02-13 2023-12-31 13F DEXCOM COM 252131107 8,359 -437,893 -98.13 1,037 -97.51 0.0020
2023-11-13 2023-09-30 13F DEXCOM COM 252131107 446,252 331,708 289.59 41,635 182.85 0.1088
2023-08-14 2023-06-30 13F DEXCOM COM 252131107 114,544 -101,030 -46.87 14,720 -41.23 0.0535
2023-05-15 2023-03-31 13F DEXCOM COM 252131107 215,574 215,574 25,045 0.1077
2022-11-14 2022-09-30 13F DEXCOM COM 252131107 0 -297,382 -100.00 0 -100.00
2022-08-15 2022-06-30 13F DEXCOM COM 252131107 297,382 297,382 22,164 0.1635
2022-05-09 2022-03-31 13F DEXCOM COM 252131107 0 -22,457 -100.00 0 -100.00
2022-02-10 2021-12-31 13F/A-1 DEXCOM COM 252131107 22,457 22,457 12,058 0.0931
2022-02-01 2021-12-31 13F DEXCOM COM 252131107 22,457 22,457 12,058 0.0932
2021-02-16 2020-12-31 13F DEXCOM COM 252131107 0 -28,131 -100.00 0 -100.00
2020-11-12 2020-09-30 13F DEXCOM COM 252131107 28,131 -18,900 -40.19 11,596 -39.18 0.1655
2020-08-14 2020-06-30 13F DEXCOM COM 252131107 47,031 47,031 19,066 0.2797
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F DEXCOM COM Call 34,300 -35.04 2,154 -38.53 n/a n/a n/a
2026-02-17 2025-12-31 13F DEXCOM COM Call 52,800 58.08 3,504 55.94 n/a n/a n/a
2025-11-14 2025-09-30 13F DEXCOM COM Call 33,400 -62.64 2,247 -71.20 n/a n/a n/a
2025-08-14 2025-06-30 13F DEXCOM COM Call 89,400 61.08 7,804 105.88 n/a n/a n/a
2025-05-15 2025-03-31 13F DEXCOM COM Call 55,500 19.10 3,790 4.58 n/a n/a n/a
2025-02-14 2024-12-31 13F DEXCOM COM Call 46,600 -20.88 3,624 -8.21 n/a n/a n/a
2024-11-14 2024-09-30 13F DEXCOM COM Call 58,900 2,577.27 3,949 1,485.54 n/a n/a n/a
2024-08-14 2024-06-30 13F DEXCOM COM Call 2,200 249 n/a n/a n/a
2024-02-13 2023-12-31 13F DEXCOM COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-13 2023-09-30 13F DEXCOM COM Call 5,800 541 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F DEXCOM COM Put 50,100 -59.50 3,146 -61.68 n/a n/a n/a
2026-02-17 2025-12-31 13F DEXCOM COM Put 123,700 4.30 8,210 2.87 n/a n/a n/a
2025-11-14 2025-09-30 13F DEXCOM COM Put 118,600 -14.37 7,981 -33.99 n/a n/a n/a
2025-08-14 2025-06-30 13F DEXCOM COM Put 138,500 -35.22 12,090 -17.20 n/a n/a n/a
2025-05-15 2025-03-31 13F DEXCOM COM Put 213,800 15.51 14,600 1.42 n/a n/a n/a
2025-02-14 2024-12-31 13F DEXCOM COM Put 185,100 171.01 14,395 214.44 n/a n/a n/a
2024-11-14 2024-09-30 13F DEXCOM COM Put 68,300 2,034.38 4,579 1,164.64 n/a n/a n/a
2024-08-14 2024-06-30 13F DEXCOM COM Put 3,200 363 n/a n/a n/a
2024-02-13 2023-12-31 13F DEXCOM COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-13 2023-09-30 13F DEXCOM COM Put 1,800 168 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.